View Post

Duke Study Challenges Mesothelioma Chemotherapy Practices

In Clinical Studies News by Barbara Jacoby

By: Tim Povtak From: Neoadjuvant chemotherapy — often used before aggressive surgery — has shown no definitive survival benefit for patients with pleural mesothelioma cancer, according to a recent study at the Duke University Medical Center. The study strengthened the growing belief among mesothelioma specialists that the combination of chemotherapy drugs cisplatin and pemetrexed might be a more effective …